Ligand validation:3OXW

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3OXW_EDO_C_104	29%	83%	0.205	0.864	0.48	0.3	-	-	0	0	100%	1
3OXW_EDO_C_103	18%	85%	0.244	0.83	0.51	0.24	-	-	0	0	100%	1
3OXW_EDO_A_102	18%	86%	0.163	0.745	0.51	0.21	-	-	0	0	100%	1
3OXW_EDO_B_103	12%	84%	0.26	0.791	0.43	0.34	-	-	0	0	100%	1
3OXW_EDO_C_102	11%	85%	0.199	0.718	0.49	0.25	-	-	0	0	100%	1
4OBH_EDO_D_105	61%	87%	0.112	0.899	0.52	0.18	-	-	0	0	100%	1
6MCR_EDO_A_103	45%	76%	0.139	0.869	0.67	0.28	-	-	0	0	100%	1
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	0	100%	1
4ITB_EDO_A_503	100%	88%	0.028	0.99	0.38	0.29	-	-	0	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.